Small Caps Begin to Rebound: 5 Stocks to Buy Now
4D Molecular Therapeutics, Inc.
Castle Biosciences Inc (CSTL)
Market is closed
News
- First
- << Previous
- 11 - 19
Is it Still Safe to Invest in Castle Biosciences (CSTL)?
Wasatch Global Investors, an investment management firm, published its "Wasatch Micro Cap Fund" fourth quarter 2021 investor letter – a copy of which can be downloaded here.
Cathie Wood's Top 15 Small-Cap Stock Picks
In this article, we discuss Cathie Wood’s top 15 small-cap stock picks.
Were Hedge Funds Right About Dumping Castle Biosciences, Inc. (CSTL)?
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Is CSTL A Good Stock To Buy Now?
In this article you are going to find out whether hedge funds think Castle Biosciences, Inc. (NASDAQ:CSTL) is a good investment right now.
Hedge Funds Are Getting Bullish On Castle Biosciences, Inc. (CSTL)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Hedge Funds Are Betting On Castle Biosciences, Inc. (CSTL)
In this article we will check out the progression of hedge fund sentiment towards Castle Biosciences, Inc. (NASDAQ:CSTL) and determine whether it is a good investment right now.
Hedge Funds Have Never Been This Bullish On Castle Biosciences, Inc. (CSTL)
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of June.
Hedge Fund and Insider Trading News: David Einhorn, Michael Hintze, Neil Woodford, Och-Ziff Capital Management, Universal Forest Products, Inc. (UFPI), Bristol-Myers Squibb Co (BMY), and More
David Einhorn has earned the attention of the investment community.
- First
- << Previous
- 11 - 19
Billionaire Hedge Funds
